@dansfera: This exposé unpacks the uncomfortable collision between profit and principle in biotech. When the FDA sends an alarming signal—like refusing to review Moderna's mRNA flu shot application—does that added risk expose our own investor bias? Navigating that ethical tightrope is tougher than any stock chart. 🤯 #BiotechInvesting #FDAControversy #mRNAFuture #StockMarketDrama